|
CA2798675A1
(en)
*
|
2010-06-01 |
2011-12-08 |
Glycom A/S |
Polymorphs of 2'-o-fucosyllactose and producing thereof
|
|
US9102966B2
(en)
*
|
2010-07-16 |
2015-08-11 |
Glycom A/S |
Synthesis of sialooligosaccharide derivatives
|
|
CA2822490C
(en)
|
2010-12-31 |
2020-03-31 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
|
MY166945A
(en)
|
2010-12-31 |
2018-07-25 |
Abbott Lab |
Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
|
|
CN107019701B
(zh)
|
2010-12-31 |
2020-07-28 |
雅培制药有限公司 |
使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
|
|
MY191538A
(en)
|
2010-12-31 |
2022-06-30 |
Abbott Lab |
Human milk oligosaccharides to promote growth of beneficial bacteria
|
|
ES2804258T3
(es)
|
2010-12-31 |
2021-02-05 |
Abbott Lab |
Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
|
|
US8802650B2
(en)
|
2010-12-31 |
2014-08-12 |
Abbott Laboratories |
Methods of using human milk oligosaccharides for improving airway respiratory health
|
|
ES2667393T3
(es)
|
2010-12-31 |
2018-05-10 |
Abbott Laboratories |
Oligosacáridos de leche humana para modular inflamación
|
|
CN103429604A
(zh)
*
|
2011-02-21 |
2013-12-04 |
格礼卡姆股份公司 |
寡糖前体的混合物的组合物的催化氢解及其用途
|
|
AU2012232727A1
(en)
*
|
2011-03-18 |
2013-09-26 |
Glycom A/S |
Synthesis of new fucose-containing carbohydrate derivatives
|
|
US20140323705A1
(en)
*
|
2011-05-13 |
2014-10-30 |
Markus Hederos |
Manufacture of lacto-n-tetraose
|
|
EP2522232A1
(en)
|
2011-05-13 |
2012-11-14 |
Nestec S.A. |
Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
|
|
CA2846603A1
(en)
|
2011-08-29 |
2013-03-07 |
Abbott Laboratories |
Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
|
|
CN103958537A
(zh)
*
|
2011-09-30 |
2014-07-30 |
格礼卡姆股份公司 |
Hmo核心结构的合成
|
|
WO2013057049A1
(en)
*
|
2011-10-18 |
2013-04-25 |
Nestec S.A. |
Composition for use in brain growth and/or cognitive and/or psychomotor development
|
|
WO2013091660A1
(en)
*
|
2011-12-23 |
2013-06-27 |
Glycom A/S |
A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
|
|
EP2861609A4
(en)
|
2012-06-14 |
2015-11-04 |
Glycom As |
IMPROVING STABILITY AND PURITY AND INCREASING THE BIOAVAILABILITY OF HUMAN MILK OLIGOSACCHARIDES OR PRECURSORS OR MIXTURES THEREOF
|
|
ITFI20120143A1
(it)
|
2012-07-12 |
2014-01-13 |
Inalco S A S Di Giovanni Cipollett I & C |
Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
|
|
EP2708147B1
(en)
*
|
2012-09-14 |
2020-03-11 |
Abbott Laboratories |
Methods for increasing brain functionality using 2-fucosyl-lactose
|
|
ES2572831T3
(es)
|
2012-09-14 |
2016-06-02 |
Abbott Laboratories |
Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
|
|
US9834574B2
(en)
|
2012-11-13 |
2017-12-05 |
Glycom A/S |
Crystalline 3-O-fucosyllactose
|
|
US20160113952A1
(en)
|
2013-05-22 |
2016-04-28 |
Glycom As |
Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
|
|
CN103408609B
(zh)
*
|
2013-09-02 |
2016-01-13 |
济南尚博生物科技有限公司 |
一种制备1-S-2,3,4-三-O-苄基-l-硫代吡喃岩藻糖苷的方法
|
|
US9902984B2
(en)
|
2013-09-06 |
2018-02-27 |
Glycom A/S |
Fermentative production of oligosaccharides
|
|
EP2857410A1
(en)
|
2013-10-04 |
2015-04-08 |
Jennewein Biotechnologie GmbH |
Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
|
|
ES2701163T3
(es)
|
2014-01-20 |
2019-02-21 |
Jennewein Biotechnologie Gmbh |
Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
|
|
CN104098615A
(zh)
*
|
2014-06-09 |
2014-10-15 |
华中科技大学 |
一种以氢氧根离子型的碱为催化剂进行脱酰基化的方法
|
|
DK3191498T3
(da)
|
2014-09-12 |
2020-12-21 |
Basf Se |
Fremgangsmåde til fremstilling af 2'-o-fucosyllactose
|
|
WO2016063262A1
(en)
|
2014-10-24 |
2016-04-28 |
Glycom A/S |
MIXTURES OF HMOs
|
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
PL3212198T3
(pl)
|
2014-10-29 |
2021-08-23 |
Glycom A/S |
Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
|
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
WO2016066175A1
(en)
|
2014-10-29 |
2016-05-06 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
|
EP3227309B1
(en)
|
2014-12-05 |
2025-09-24 |
Glycom A/S |
Crystalline difucosyllactose
|
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
CN107106584A
(zh)
|
2014-12-08 |
2017-08-29 |
格礼卡姆股份公司 |
用于治疗代谢障碍的合成组合物
|
|
ES2960750T3
(es)
|
2015-03-05 |
2024-03-06 |
Glycom As |
Oligosacáridos de la leche humana para el tratamiento de infecciones agudas del aparato respiratorio
|
|
PL3277287T3
(pl)
|
2015-03-31 |
2024-04-22 |
Glycom A/S |
Mieszaniny oligosacharydów mleka ludzkiego zawierające 3'-O-sialilolaktozę
|
|
PL3307752T3
(pl)
|
2015-06-09 |
2021-11-02 |
Glycom A/S |
Mieszaniny trójskładnikowe 6’-sl, lnnt i lst c
|
|
RU2634707C2
(ru)
*
|
2015-07-23 |
2017-11-03 |
Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства |
Способ избирательного удаления О-ацетильных защитных групп в присутствии О-бензоильных
|
|
US10751354B2
(en)
|
2015-09-14 |
2020-08-25 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US10835545B2
(en)
|
2015-10-28 |
2020-11-17 |
Glycom A/S |
Synthetic composition and method for modulating brain function and behaviour
|
|
US10780103B2
(en)
|
2015-10-28 |
2020-09-22 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
|
PL3377071T3
(pl)
|
2015-11-17 |
2024-06-24 |
Glycom A/S |
Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
|
|
EP3389404B1
(en)
|
2015-12-15 |
2019-10-02 |
Société des Produits Nestlé S.A. |
Mixture of hmos
|
|
CN108602845A
(zh)
*
|
2016-02-03 |
2018-09-28 |
巴斯夫欧洲公司 |
生产2’-o-岩藻糖基乳糖的方法
|
|
WO2017144062A1
(en)
|
2016-02-24 |
2017-08-31 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
WO2017153452A1
(en)
|
2016-03-09 |
2017-09-14 |
Basf Se |
Method for preparing 2'-o-fucosyllactose
|
|
KR101731263B1
(ko)
|
2016-04-25 |
2017-05-02 |
서울대학교 산학협력단 |
코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법
|
|
PL3452050T3
(pl)
|
2016-05-05 |
2023-06-12 |
Glycom A/S |
Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
|
|
WO2017190755A1
(en)
|
2016-05-05 |
2017-11-09 |
Glycom A/S |
Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
|
|
CN105924480B
(zh)
*
|
2016-05-10 |
2018-09-25 |
浙江大学 |
含岩藻糖三糖硫酸酯及其制备方法和应用
|
|
WO2017198276A1
(en)
|
2016-05-19 |
2017-11-23 |
Glycom A/S |
Synthetic composition
|
|
EP3474861A4
(en)
|
2016-06-24 |
2020-04-15 |
Glycom A/S |
COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
|
|
US11278558B2
(en)
|
2017-03-01 |
2022-03-22 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US11291677B2
(en)
|
2017-05-09 |
2022-04-05 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
US11541068B2
(en)
|
2017-05-24 |
2023-01-03 |
Glycom A/S |
HMO compositions and methods for reducing autism spectrum disorder symptoms
|
|
EP3630123A4
(en)
|
2017-05-24 |
2020-10-28 |
Glycom A/S |
SYNTHETIC COMPOSITION CONSISTING OF ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
|
|
EP3672600A4
(en)
|
2017-08-21 |
2021-05-19 |
Glycom A/S |
SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
|
|
EP3450443A1
(en)
|
2017-08-29 |
2019-03-06 |
Jennewein Biotechnologie GmbH |
Process for purifying sialylated oligosaccharides
|
|
CA3076920A1
(en)
|
2017-10-04 |
2019-04-11 |
The Regents Of The University Of California |
Immunomodulatory oligosaccharides
|
|
CN111526879A
(zh)
|
2017-11-02 |
2020-08-11 |
格礼卡姆股份公司 |
用于减少或预防疲劳和/或改善注意力或专注力的一种或多种hmo
|
|
JP7327724B2
(ja)
|
2017-11-30 |
2023-08-16 |
グリコム・アクティーゼルスカブ |
小麦過敏症を処置するためのhmoの混合物
|
|
WO2019111115A2
(en)
|
2017-12-05 |
2019-06-13 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
|
CN111683666A
(zh)
|
2017-12-22 |
2020-09-18 |
格礼卡姆股份公司 |
预防或减少伤害感受的包含hmo的组合物
|
|
CN108084234A
(zh)
*
|
2018-01-23 |
2018-05-29 |
佛山科学技术学院 |
双重随机糖基化合成三糖的方法
|
|
EP3801558A4
(en)
|
2018-05-31 |
2022-03-09 |
Glycom A/S |
HMOS BLEND FOR THE TREATMENT OF AUTOIMMUNE DISEASES
|
|
EP3867258A1
(en)
|
2018-10-18 |
2021-08-25 |
Basf Se |
Method for obtaining crystalline 2'-fucosyllactose
|
|
US12233079B2
(en)
|
2018-12-19 |
2025-02-25 |
Glycom A/S |
Composition and method for treating humans using low-fodmap diets
|
|
EP3741770A1
(en)
|
2019-05-21 |
2020-11-25 |
Jennewein Biotechnologie GmbH |
Purification of oligosaccharides from a fermentation broth by using filtration
|
|
JP7833397B2
(ja)
|
2019-11-29 |
2026-03-19 |
グリコム・アクティーゼルスカブ |
妊婦の細菌叢を改善するためのhmoの混合物
|
|
KR20220154158A
(ko)
|
2020-03-12 |
2022-11-21 |
글리콤 에이/에스 |
2'-fl의 결정화
|
|
CN111588726A
(zh)
*
|
2020-04-28 |
2020-08-28 |
南开大学 |
2′-岩藻糖基乳糖调节宿主肠道菌群及增强肠屏障的应用
|
|
WO2022118269A1
(en)
|
2020-12-04 |
2022-06-09 |
Glycom A/S |
Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
|
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
|
WO2023099297A1
(en)
*
|
2021-12-02 |
2023-06-08 |
Dsm Ip Assets B.V. |
Synthesis of hmo butyrate
|
|
KR20250036879A
(ko)
|
2022-07-15 |
2025-03-14 |
디에스엠 아이피 어셋츠 비.브이. |
Nmn 또는 nad+의 증가에 사용하기 위한 비피도박테리움 및 푸코실화된 hmo의 조합물
|
|
CN120187736A
(zh)
*
|
2022-11-15 |
2025-06-20 |
洛桑联邦理工学院 |
制备至少部分缩醛保护的糖的方法
|
|
WO2025196273A1
(en)
|
2024-03-22 |
2025-09-25 |
Dsm Ip Assets B.V. |
Combination of mixtures of hmos with mfgm and their use
|
|
WO2025196272A1
(en)
|
2024-03-22 |
2025-09-25 |
Dsm Ip Assets B.V. |
Combination of mixtures of hmos with mfgm and their use
|
|
WO2025219496A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
Nutritional composition comprising bifidobacterium longum ssp. infantis r0033 and human milk oligosaccharides
|
|
WO2025219497A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
Combination comprising bifidobacterium bifidum ha-132 and human milk oligosaccharides
|
|
WO2025219495A1
(en)
|
2024-04-19 |
2025-10-23 |
Dsm Ip Assets B.V. |
A nutritional composition comprising bifidobacterium bifidum r0071 and human milk oligosaccharides
|